Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV-1/HBV Co-Infection”

10 trials

Showing 10 of 10 results

Not applicableEnrolling By InvitationNCT02699736
What this trial is testing

EuroSIDA - Clinical and Virological Outcome of European Patients Infected With HIV

Who this might be right for
HIVHepatitis BHepatitis C+10 more
Rigshospitalet, Denmark 23,000
Post-approval studies (Phase 4)Study completedNCT03797014
What this trial is testing

B/F/TAF Switch Study for HIV-HBV Coinfection

Who this might be right for
HIV-1-infectionHepatitis B
University of Maryland, Baltimore 28
Large-scale testing (Phase 3)Study completedNCT00190242
What this trial is testing

Immunogenicity and Tolerance of Two Strategies of Anti-HAV Vaccination in HIV-infected Patients

Who this might be right for
HIV Infection
Assistance Publique - Hôpitaux de Paris 99
Large-scale testing (Phase 3)Study completedNCT02071082
What this trial is testing

Efficacy and Safety of E/C/F/TAF (Genvoya®) in HIV-1/Hepatitis B Co-infected Adults

Who this might be right for
HIVHBV
Gilead Sciences 79
Large-scale testing (Phase 3)Study completedNCT03547908
What this trial is testing

Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment Naive, HIV-1 and Hepatitis B Co-Infected Adults

Who this might be right for
HIV-1/HBV Co-Infection
Gilead Sciences 244
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06338826
What this trial is testing

Study Evaluating the Safety, in Terms of HBV Virological Control At 96 Weeks, of 2 Antiviral Treatment Relief Strategies, in Patients Co-infected with the HIV-1 and HBV Viruses

Who this might be right for
HIV InfectionsHBV Coinfection
ANRS, Emerging Infectious Diseases 140
Post-approval studies (Phase 4)Study completedNCT00127959
What this trial is testing

Virological and Clinical Anti-Hepatitis B Virus (HBV) Efficacy of Tenofovir and Emtricitabine in Patients With HIV/HBV co-Infection

Who this might be right for
HIV InfectionsHepatitis B
International Antiviral Therapy Evaluation Center 24
Not applicableUnknownNCT03425994
What this trial is testing

Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide as Maintenance Treatment for HIV/HBV-coinfection

Who this might be right for
Chronic Hepatitis B in HIV PatientKidney InjuryBone Diseases
National Taiwan University Hospital 275
Post-approval studies (Phase 4)WithdrawnNCT00782301
What this trial is testing

Maraviroc Versus Etravirine In Combination With Antiretroviral Therapy In Drug Experienced HIV And Hepatitis Co-Infected Patients

Who this might be right for
Hepatitis BHuman Immunodeficiency VirusHepatitis C, Chronic
ViiV Healthcare
Post-approval studies (Phase 4)Study completedNCT01327547
What this trial is testing

Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B

Who this might be right for
HIV Coinfection
ViiV Healthcare 138

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation